I'm wondering if Adam and Johnny was there during the conference and heard something about the courtship of Roche and Regen...from Jason Coloma.
At Roche we are looking for first-in-class or best-in-class opportunities that address diseases ofunmet medical needand have the potential to revolutionise the standard of care.. We focus on our main disease therapy areas – oncology and immunology, ophthalmology, virology, cardiometabolism and neuroscience–as well as looking at opportunities in promising technologies and early-stage collaborations. Beyond the asset, we always look for the right partnership and cultural fit.
Strategic Partnering Within the organisation, the Strategic Partnering team will consider a range of deal types including mergers and acquisitions (M&A); alliances covering more than one therapeutic area; divestments; and in-licensing opportunities that do not fall within Roche’s key therapy areas of interest.
Bio-Matrix Scientific Group, Inc. ( PINKSHEETS : BMSN ) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs.Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indication
Miss Regen is a perfect match with Mr.Roche They will meet and be together again this year...
Happy Reserving plenty of reservations under a pnny for the Grand-Wedding.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.